Dual PI3K/MTOR Inhibitors: A Promising Advance in Head and Neck Cancer Treatment?
Discover how dual PI3K/MTOR inhibitors like PF-04691502 could revolutionize head and neck cancer treatment by boosting radiation effectiveness and tackling drug resistance. Learn about the latest research and its implications.